Acceleron Pharma Inc. Banner Image

Acceleron Pharma Inc.

  • Ticker XLRN
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Acceleron Pharma Inc. Logo Image
  • 51-200 Employees
  • Based in Cambridge, Massachusetts
Acceleron Pharma Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of protein therapeutics for cancer and rare diseases. It develops sotatercept and ACE-536 that are in Phase II clinical trials to treat anemia and associated complications in patients with ß-thalassemia and myelodysplastic syndromes, and red blood cell disordersMore; and dalantercept, which is in Phase II clinical trials to inhibit blood vessel formation in tumors through the vascular endothelial growth factor pathway inhibitors.
4.8 / 5.0 (315)

Acceleron Pharma Inc. reports have an aggregate usefulness score of 4.8 based on 315 reviews.

Acceleron Pharma Inc.

Most Recent Annual Report

Acceleron Pharma Inc.
MOST RECENT 2020 Annual Report and Form 10K

Acceleron Pharma Inc. does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports

Acceleron Pharma Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!